With the Yaz birth-control multidistrict litigation led almost entirely by men, the evidence that women are less likely to be first chairs at trials across the legal industry, and the occasional story about old-guard leadership jockeying to ensure continued appointments on steering committees, anecdotal evidence suggests women are underrepresented in leadership positions on plaintiffs’ steering committees in MDLs and mass torts.
Although many attorneys say the situation is improving—in large part through efforts from both the judiciary and attorneys who work in the arena—soon hard evidence may be coming forward outlining exactly the disparity mass litigations are facing when it comes to female attorneys serving on leadership panels.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
